New PBS listing for migalastat (Galafold®) for the treatment of Fabry disease
19 Aug 2024
Access to migalastat for new patients under the Life Saving Drugs Program (LSDP) will cease from 1 September 2024, with transition arrangements in place to facilitate access through the PBS for patients currently undergoing treatment.
Further information about the transition arrangements for treating physicians and patients can be found on the LSDP webpage.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
- Medicine Shortage
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy
